Kellie Ann Jurado is a Presidential Assistant Professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania. [1] She is the Principal Investigator at the Jurado Lab. Her team studies early life immunity using emerging viruses. [1] Jurado has published many research papers on topics such as impact of the Zika virus on cells and the HIV-1 virus. [2] Jurado specializes in research on early-life immunity- which has been proven to effect life-long health. [3]
Jurado grew up in a small town in southern New Mexico and comes from a family of Mexican heritage. Most of her family members have a business and agricultural background. Her grandfather and father were chili farmers. [4]
She earned her Bachelor of Sciences (BS) from New Mexico State University, [2] and she received her Ph.D. from Harvard University. Then she completed her postdoctoral training at Yale University. [1]
In 2022, Jurado received Christina Fleischmann Award to Young Women Investigators Award. [1] In 2022, she was also named as one of the 20 Packard Fellows. She received the fellowship for being an innovative scientist for pursuing research new areas. [5]
In 2020, she was named as one of the Cell Mentor's 100 Inspiring Hispanic/Latinx Scientists in America. The recipients were selected based on scholarly achievement and commitment to diversity, equity, and inclusion. [6]
In 2017, Jurado was awarded L'Oreal USA 2017 for Women in Science along with four other women scientists. Grants were awarded to them for their groundbreaking research and commitment to closing the gender gap in STEM fields. [7]
Interferons are a group of signaling proteins made and released by host cells in response to the presence of several viruses. In a typical scenario, a virus-infected cell will release interferons causing nearby cells to heighten their anti-viral defenses.
Jan T. Vilček is a Slovak-American biomedical scientist, educator, inventor and philanthropist. He is a professor in the department of microbiology at the New York University School of Medicine, and chairman and CEO of The Vilcek Foundation. Vilček received his M.D. degree from Comenius University Medical School in Bratislava in 1957; and his Ph.D. in Virology from the Institute of Virology, Czechoslovak Academy of Sciences, Bratislava, in 1962.
Interleukin-29 (IL-29) is a cytokine and it belongs to type III interferons group, also termed interferons λ (IFN-λ). IL-29 plays an important role in the immune response against pathogenes and especially against viruses by mechanisms similar to type I interferons, but targeting primarily cells of epithelial origin and hepatocytes.
Interferon alpha-2 is a protein that in humans is encoded by the IFNA2 gene.
Interferon regulatory factor 5 is a protein that in humans is encoded by the IRF5 gene. The IRF family is a group of transcription factors that are involved in signaling for virus responses in mammals along with regulation of certain cellular functions.
Anne O'Garra FRS FMedSci is a British immunologist who has made important discoveries on the mechanism of action of Interleukin 10.
Ann M. Arvin is an American pediatrician and microbiologist. She is the Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology & Immunology Emerita at Stanford University. Arvin is a specialist of the Varicella zoster virus (VZV) and a prominent national figure in health. Arvin is currently the chief of the infectious diseases division of pediatrics at the Lucile Packard Children's Hospital, as well as the former Stanford's Vice Provost and Dean of Research.
Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19, and long COVID.
Misty Rayna Jenkins is an Australian scientist known for her research into lymphocytes and cancer treatment.
Thirumala-Devi Kanneganti is an immunologist and is the Rose Marie Thomas Endowed Chair, Vice Chair of the Department of Immunology, and Member at St. Jude Children's Research Hospital. She is also Director of the Center of Excellence in Innate Immunity and Inflammation at St. Jude Children's Research Hospital. Her research interests include investigating fundamental mechanisms of innate immunity, including inflammasomes and inflammatory cell death, PANoptosis, in infectious and inflammatory disease and cancer.
Carol Shoshkes Reiss, an American viral immunologist, was a professor at New York University's Department of Biology between 1991 and 2020. She is currently a professor emerita at New York University. Her research focused on the dynamic contest between the mouse immune system and virus replication during central nervous system infection. Reiss was editor-in-chief of the journal Viral Immunology (2000–2006) and is currently editor-in-chief of the journal DNA and Cell Biology (2012–present).
Susan R. Weiss is an American microbiologist who is a Professor of Microbiology at the Perelman School of Medicine at the University of Pennsylvania. She holds vice chair positions for the Department of Microbiology and for Faculty Development. Her research considers the biology of coronaviruses, including SARS, MERS and SARS-CoV-2. As of March 2020, Weiss serves as Co-Director of the University of Pennsylvania/Penn Medicine Center for Research on Coronavirus and Other Emerging Pathogens.
Sara R. Cherry is an American microbiologist who is John W. Eckman Professor of Medical Science and Professor of Microbiology in Biochemistry and Biophysics at the Perelman School of Medicine at the University of Pennsylvania. Her research involves genetic and mechanistic studies of virus–host interactions. During the COVID-19 pandemic, Cherry looked to identify novel therapeutic strategies.
Karen Louise Mossman is a Canadian virologist who is a professor of Pathology and Molecular Medicine at McMaster University. Mossman looks to understand how viruses get around the defence mechanisms of cells. She was part of a team of Canadian researchers who first isolated SARS-CoV-2.
Eleanor N. Fish is a Canadian immunologist who is a Professor of Immunology at the University of Toronto. Her research considers how cytokines and chemokines interact with receptors in cells and tissue. During the COVID-19 pandemic, Fish tested interferon-alpha as a treatment for coronavirus disease.
The International Cytokine & Interferon Society (ICIS) is a non-profit organization composed of researchers of cytokines, interferons and chemokine cell biology, molecular biology, biochemistry, and the use of biological response modifiers clinically. As the premier organization in the field of cytokine biology, it has more than 950 member scientists and holds annual conferences around the world.
Shruti Naik is an Indian American scientist who is known for her interdisciplinary research in immunology and adult stem cell biology. She is an Associate Professor of Dermatology, Immunology and Immunotherapy, and Institute of Regenerative Medicine and Director of the Tissue Repair Program at Icahn School of Medicine at Mount Sinai. Her lab combines approaches from the fields of immunology, microbiology, stem cell biology, and cancer biology with cutting-edge imaging and sequencing technologies to discover new ways of treating inflammatory diseases.
Carla V. Rothlin is an Argentinian immunologist. She is a professor of immunobiology at Yale University, where she holds the Dorys McConnell Duberg Professorship, and also serves as a professor of pharmacology. Rothlin is the co-leader of the Cancer Immunology Program at Yale Cancer Center and a Howard Hughes Medical Investigator Faculty Scholar.
Lydia Lynch, immunologist, studies the effects of obesity and diet on immune cell functions. She was named a 2009 Fellow of the L'Oréal-UNESCO For Women in Science Award, and she directs the Lynch Lab at Brigham and Women’s Hospital.
Georgina Xanthou is an immunologist who serves as an associate professor at the Biomedical Research Foundation of the Academy of Athens.